The Technical Analyst
Select Language :
Entera Bio Ltd [ENTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Entera Bio Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals

Entera Bio Ltd is listed at the  Exchange

8.44% $1.670

America/New_York / 28 mar 2024 @ 16:00


Entera Bio Ltd: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 59.25 mill
EPS: -0.310
P/E: -5.39
Earnings Date: May 03, 2024
SharesOutstanding: 35.48 mill
Avg Daily Volume: 0.143 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/a
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -5.39 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.92x
Company: PE -5.39 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.366
(-78.06%) $-1.304
Date: 2024-03-28
Expected Trading Range (DAY)

$ 1.505 - 1.835

( +/- 9.88%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-12 Taitel Haya Buy 9 500 Ordinary Shares, par value NIS 0.0000769 per share
2024-01-10 Taitel Haya Buy 7 615 Ordinary Shares, par value NIS 0.0000769 per share
2024-01-01 Taitel Haya Buy 108 333 Stock Option (right to buy)
2024-01-01 Garceau Roger Buy 108 333 Stock Option (right to buy)
2024-01-01 Malca Yonatan Buy 108 333 Stock Option (right to buy)
INSIDER POWER
100.00
Last 89 transactions
Buy: 4 333 534 | Sell: 4 161 674

Forecast: 16:00 - $1.640

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $1.640
Forecast 2: 16:00 - $1.640
Forecast 3: 16:00 - $1.640
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.670 (8.44% )
Volume 0.124 mill
Avg. Vol. 0.143 mill
% of Avg. Vol 87.22 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Entera Bio Ltd

Last 12 Months

Last 12 months chart data with high, low, open and close for Entera Bio Ltd

RSI

Intraday RSI14 chart for Entera Bio Ltd

Last 10 Buy & Sell Signals For ENTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Entera Bio Ltd

ENTX

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.

Last 10 Buy Signals

Date Signal @
PEOPLEUSDMar 28 - 17:590.0398
MBOXUSDMar 28 - 17:580.473
GALXUSDMar 28 - 17:585.08
^NYAMar 28 - 17:40PTS18 255
RBTCUSDMar 28 - 17:57$70 251
ORNUSDMar 28 - 17:59$2.31
YFIUSDMar 28 - 17:57$8 975.00
RAYUSDMar 28 - 17:56$2.00
SFUNDUSDMar 28 - 17:53$4.37
UNFIUSDMar 28 - 17:537.51

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.